Joint Diseases (Joint Disease)

Subscribe to Selected New Research on Joint Diseases

1496 relevant articles (53 outcomes, 131 trials/studies) found for this Disease

Also Known As:

Joint Disease; Disease, Joint; Diseases, Joint

Relationship Network

Disease Context: Research Results

Related Diseases

1.	Rheumatoid Arthritis
2.	Arthritis (Polyarthritis)
3.	Experimental Arthritis
4.	Pain (Aches)
5.	Osteoarthritis
238 Diseases and 547 more articles analyzed in the Full Patient-Physician Summary Report, order at left...

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Joint Diseases:

1.	Diclofenac (SR 38)FDA LinkGeneric 01/01/2004 - "A topical 1% diclofenac liposomal cream proved to be safe, easy to use, and effective in reducing equine lameness caused by degenerative joint disease" 05/01/1991 - "Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease." 01/01/1992 - "In conclusion, the results of the present study indicate that 600 mg etodolac SR once daily for 4 weeks is effective in the treatment of patients with degenerative joint disease of the knee, as is 100 mg diclofenac SR. In addition, both drugs have comparable tolerability profiles." 04/01/1999 - "Comparison of therapeutic efficacy of nimesulide and diclofenac in patients with degenerative joint diseases." 04/01/2003 - "Diclofenac suppositories in the treatment of bone and joint diseases" Get all the results and reference details, order at left...
2.	infliximab (Remicade)FDA Link 05/01/2002 - "CONCLUSION: Infliximab appears to be effective and well tolerated for both axial and peripheral joint disease in AS even at lower doses than those examined to date" 07/01/2006 - "Pharmacoeconomic study of patients with chronic inflammatory joint disease before and during infliximab treatment." 06/01/2007 - "Patients with active chronic inflammatory joint disease were introduced into the infliximab therapy programme" 06/01/2007 - "OBJECTIVE: To evaluate infliximab effect on oxidative stress in active chronic inflammatory joint disease" 06/01/2007 - "The effect of infliximab on oxidative stress in chronic inflammatory joint disease." Get all the results and reference details, order at left...
3.	Hyaluronic Acid (Hyaluronan)IBA 04/01/2004 - "Hyaluronic acid minimally effective for knee degenerative joint disease." 07/01/2006 - "REASONS FOR PERFORMING STUDY: Hyaluronan (HA) has been used to treat joint disease via intra-articular, i.v. and oral administration" 09/01/2004 - "REASONS FOR PERFORMING STUDY: Hyaluronic acid (HA) is an endogenous glycosaminoglycan used in the treatment of joint diseases, but medication control is required by horseracing authorities" 05/04/2007 - "Our data showed the protective effect of the extracts of Opuntia ficus indica cladodes in cartilage alteration, which appears greater than that elicited by hyaluronic acid (HA) commonly employed as visco-supplementation in the treatment of joint diseases." 07/01/2006 - "CONCLUSIONS AND POTENTIAL RELEVANCE: Oral preparations of hyaluronan are being used to treat joint disease in horse" Get all the results and reference details, order at left...
4.	Indomethacin (Indometacin)FDA LinkGeneric 07/01/2006 - "Our data showed the protective effects of JW-E in cartilage alteration, that appears greater than that elicited by indomethacin, a not steroidal antiinflammatory drug (NSAID), commonly employed in joint diseases." 09/01/1981 - "1. Twelve treated hypertensive patients (ages 58-71 years) who had also been treated for joint disease participated in a randomized double-blind crossover placebo-controlled study to investigate the effects of indomethacin (25 mg three times daily) on blood pressure and biochemical parameters over a 6-week period" 09/30/2005 - "This protection appeared to be greater than that elicited by indomethacin, which is usually employed in joint diseases" 11/01/1991 - "Indomethacin 10(-5) and 10(-7)mol/l inhibited the PG release from synovial tissue in all joint diseases significantly (p less than 0.05), there was no significant effect on the LT release" 12/15/1978 - "Comparison of indomethacin-retard and indomethacin for degenerative joint diseases--a double-blind study]" Get all the results and reference details, order at left...
5.	Etodolac (Lodine)FDA LinkGeneric 01/01/1994 - "Efficacy and tolerability of etodolac in aged patients affected by degenerative joint disease (osteoarthritis) in its active phase." 01/01/1992 - "In conclusion, the results of the present study indicate that 600 mg etodolac SR once daily for 4 weeks is effective in the treatment of patients with degenerative joint disease of the knee, as is 100 mg diclofenac SR. In addition, both drugs have comparable tolerability profiles." 07/01/1992 - "Safety and efficacy of etodolac compared with piroxicam in patients with degenerative joint disease of the knee." 01/01/1983 - "Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week study." 03/01/1996 - "Influence of severity of chronic inflammatory joint disease on the pharmacokinetics of indomethacin and etodolac." Get all the results and reference details, order at left...
6.	Interleukin-6 (Interleukin 6)IBA 09/01/2006 - "Development of an H1 antagonist that inhibits the release of IL-6 from synoviocytes may be beneficial for the treatment of inflammatory joint disease." 01/31/2003 - "These IL-6 effects might contribute to the phenotype loss of chondrocytes in joint diseases and the alteration of articular cartilage associated with this pathology." 11/01/2001 - "IL-6 was the most sensitive and specific for joint disease and could be an excellent screening test for the presence of joint disease when lameness is difficult to identify or is intermittent" 11/01/2001 - "Any IL-6 in synovial fluid indicated joint disease and correlated highly with synovial fluid white blood cell count (P <.0001)" 11/01/2001 - "RESULTS: TNF synovial fluid concentration as a predictor of joint disease was good, and the value of TNF (maximum S and Sp) indicating joint disease was >36 pg/mL. IL-1beta as a predictor of joint disease was good, and the value of IL-1beta indicating joint disease was >4.5 pg/mL. IL-6 concentration was an excellent predictor of joint disease" Get all the results and reference details, order at left...
7.	Collagen Type II (Type II Collagen)IBA 07/01/2006 - "OBJECTIVE: To characterize and validate a novel, enzyme-linked immunoassay for measuring cross-linked dimer forms of C-terminal telopeptides of type II collagen (CTX-II) in serum and synovial fluid of rodents, and investigate whether CTX-II measurements can reflect joint status in two established animal models of destructive joint diseases" 07/01/2006 - "The utility of measuring C-terminal telopeptides of collagen type II (CTX-II) in serum and synovial fluid samples for estimation of articular cartilage status in experimental models of destructive joint diseases." 06/01/2003 - "Preliminary results with quantitative assays of type II collagen neoepitopes suggest that they may be useful markers of joint disease in humans" 12/01/2000 - "METHODS: To determine the effect of TSG-6 on chronic inflammatory joint disease, we induced CIA in DBA/1J mice by immunization with bovine type II collagen" 12/01/1989 - "Anti-type II collagen antibody in naturally occurring canine joint diseases." Get all the results and reference details, order at left...
8.	A73025IBA 11/01/1996 - "CLINICAL IMPLICATIONS: Use of PSGAG is regarded as moderately effective overall and is considered most useful in the treatment of subacute degenerative joint disease" 11/01/1996 - "Use of PSGAG was reported to be moderately effective in the treatment of the 4 joint disease conditions" 11/01/1996 - "OBJECTIVE: To determine the patterns of use and perceived efficacy of polysulfated glycosaminoglycan (PSGAG) for the treatment of degenerative joint disease in horses" 05/01/1990 - "Nonetheless, these observations provide direct evidence of a truly chondroprotective role for low molecular weight PSGAG in the treatment of equine degenerative joint disease." 11/01/1996 - "PROCEDURE: Information was obtained on frequency and route of administration of PSGAG for the treatment of each of 4 forms of degenerative joint disease, the efficacy of PSGAG, and its efficacy compared with that of sodium hyaluronate" Get all the results and reference details, order at left...
9.	amsonic acid (DAS)IBA 05/01/2006 - "OBJECTIVE: To compare 28 joint disease activity score (DAS28) remission with comprehensive joint count DAS remission in rheumatoid arthritis" 01/01/2006 - "METHODS: Four steps were employed: (1) review of published reports on DMARD efficacy against rheumatoid arthritis; (2) inventory of the information available to guide DMARD choice; (3) selection of the most pertinent information by 12 experts using a Delphi method; and (4) choice of DMARDs in 12 clinical situations defined by items selected in step 3 (28 joint disease activity score (DAS 28): < or =3.2; >3.2 and < or =5.1; >5.1; rheumatoid factor status (positive/negative); structural damage (with/without)-that is, 3 x 2 x 2)" Get all the results and reference details, order at left...
10.	CollagenIBA 03/01/1998 - "This study aims to assess the production and tissue distribution of this enzyme in normal and diseased synovia from patients with various joint diseases, on the basis that it is a putative marker of collagen-producing cells and, therefore, in this context, of fibroblasts" 07/01/2007 - "Therefore, we suggest that (1) LDH is transferred from chondrocytes to ECM in both healthy dogs and dogs with degenerative joint disease and that (2) in degenerative joints, LDH is released from chondrocytes and the ECM into synovial fluid through abrasion of cartilage as well as through enhanced diffusion as a result of increased water content and degradation of collagen." 04/01/2005 - "Alterations of collagen matrix associated with advanced degenerative joint disease (fibrocartilage) were observed with NLOM" 06/01/2004 - "The measurement of type IIA collagen synthesis with this new molecular marker may be useful for the clinical investigation of patients with joint diseases." 02/20/2004 - "A critical event in the process of cartilage destruction in joint disease is the failure of the collagen fiber network to maintain integrity" Get all the results and reference details, order at left...
656 Drugs and Important Bio-Agents and 1272 more articles analyzed in the Full Patient-Physician Summary Report, order at left...

Therapies and Procedures

1.	Arthroplasty 10/01/1982 - "Total hip arthroplasty should not be recommended for the young patient who has one or two joint diseases and no limiting systemic factors, with the expectation that when the total hip fails, it can be converted to a resection arthroplasty and the patient improved as compared with the pre-total hip status" 05/01/1992 - "Although comparative studies between THA and excision arthroplasty have not been reported, our experience with both procedures and studies in the literature support THA as the best available treatment for crippling degenerative joint disease secondary to CHD in large, mature dogs" 06/01/2006 - "The main indication for arthroplasty was degenerative joint disease" 06/01/2006 - "Total ankle arthroplasty in inflammatory joint disease with use of two mobile-bearing designs." 01/01/2006 - "However, in the young, active patient or in those without advanced disease, joint arthroplasty may not be appropriate" Get all the results and reference details, order at left...
2.	Balneology 03/31/1973 - "Balneotherapy of inflammatory and degenerative joint diseases]" 03/01/1967 - "The possibilites of physical therapy of inflammatory joint diseases including balneotherapy]" 05/01/2008 - "BACKGROUND: Balneotherapy is an established treatment modality for musculoskeletal disease, but few studies have examined the efficacy of spa therapy in elderly patients with degenerative spine and joint diseases" Get all the results and reference details, order at left...
3.	Osteotomy 05/01/1998 - "Specific aims included documenting the time of and extent of improved limb function as measured by force plate analysis, evaluating the progression of degenerative joint disease (DJD) in the treated and untreated coxofemoral joints, and determining whether or not triple pelvic osteotomy resulted in degenerative joint changes in the ipsilateral stifle and hock" 10/01/2008 - "Corrective osteotomy may be a reasonable option for proximal humeral malunions in young patients without evidence of degenerative joint disease" 11/01/2007 - "Does Weber's rotation osteotomy induce degenerative joint disease at the shoulder in the long term?" 06/01/1999 - "The periacetabular osteotomy is a well established surgical procedure for the preventative treatment of degenerative joint disease caused by symptomatic acetabular dysplasia" 07/01/1998 - "OBJECTIVE: To determine whether preoperative radiographic evidence of degenerative joint disease (DJD), hip joint laxity, or age at surgery is associated with long-standing DJD or hip function in dogs with hip dysplasia (HD) that had a triple pelvic osteotomy (TPO)" Get all the results and reference details, order at left...
4.	Laser Therapy (Surgery, Laser) 01/01/1995 - "The efficacy of mid-laser therapy has been tested specifically on patients with degenerative joint disease (DJD) involving the temporomandibular joint (TMJ)" 01/01/1997 - "Biostimulating laser therapy as one method of treating bone and joint diseases]" Get all the results and reference details, order at left...
5.	Ambulatory Care (Outpatient Care) 02/01/1997 - "Outcome was defined by (1) the development of erosions of the hands, wrists or feet and (2) the number of patients in remission (clinically inactive disease on two clinic visits 3 months apart with no intervening history of inflammatory joint disease)" 01/01/1975 - "Estimates of need for outpatient care for joint disease exceeded provided treatment by only 1.7 times" Get all the results and reference details, order at left...
86 Therapies and Procedures and 253 more articles analyzed in the Full Patient-Physician Summary Report, order at left...

Patient-Physician Research Summary Report on Joint Diseases

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 53 Outcomes
Top 200 Key Medications
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF for "Psoriasis" >>

Price:

$24.00 & Delivery via PDF download,
updates for 1 year

Proceed to Checkout >>

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>